drugset / Trial / NCT00660985
Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase 4 commitment pharmacokinetic study to determine systemic exposure to adapalene.
Timeline
- Start
- 2008-05
- Primary completion
- 2008-08
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Adapalene | Other / unclassified | 0.1 % | Topical |
| Comparator | Adapalene | Other / unclassified | 0.3 % | Topical |